SGHT
Sight Sciences, Inc. · Healthcare
Director and 10% owner Staffan Encrantz bought $382K of Sight Sciences, Inc.
Bought$381,958
$4.22Price
90,525Shares
+1%Stake
What SGHT did for a copier
- $1,000 copied at Mon, Jun 9 open, $4.25
- $889
- S&P 500, same days
- +6.1%
Measured over 30 trading days, to the Jul 23 close.
Staffan Encrantz's record
8 other buys with 3 months of prices since 2021: on average −4.1% against the S&P 500, and 3 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Jun 4. Filed Fri, Jun 6, 9:10 PM ET, after the close. Returns use the Jun 9 open and the Jul 23 close. Not investment advice.